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Pancreatic insufficiency after gastrointestinal surgery is of great
importance as it is directly related to a patient’s nutritional status.
Unfortunately, the gravity of the situation is usually underesti-
mated and treatment is often not administered, resulting in mal-
nutrition, weight loss and impaired quality of life.1
The gastro–pancreatico–duodenal complex plays an important
role in the digestion of food. The initiation of digestion starts
within the stomach with the action of pepsin and hydrochloric
acid. Then the small nutrient particles arrive in the duodenum
and mix with the biliopancreatic secretions. The gastric emptying
process is coordinated by two main reflexes: the antro-fundic and
the duodenogastric. At the same time, fundic distension and the
presence of nutrients in the duodenum provoke pancreatic secre-
tion through the release of cholecystokinin (CCK) and the main
digestive function starts.
The alteration of gastrointestinal anatomy as a result of any of
a variety of different surgical procedures targeting the stomach
and the pancreas has a direct impact on digestion. Because of the
loss of normal gastric emptying and hormone release, gastric
resection has been proven in a number of studies to lead to a
decrease in pancreatic juice volume and consequently the secre-
tion of enzymes such as trypsin, chymotrypsin and amylase, as
well as a reduction in bicarbonates. This also happens following
pancreatic resection, regardless of its extent, at least during the
first fewmonths after surgery.Although there are some differences
in CCK release and consequently in the severity of malnutri-
tion after different operations (e.g. Kausch–Whipple resection
or pylorus-preserving pancreatic resection), the implications of
these have not been proven in the published randomized studies
looking at this issue.2
Diagnosis of malnutrition caused by exocrine pancreatic
insufficiency (EPI) is mainly based on clinical grounds. As oral
pancreatic enzyme replacement therapy (PERT) has been proven
efficient in controlling malnutrition, there is a need for a specific
test that can detect the level of exocrine pancreatic function in
the circumstances of gastric or pancreatic resection, in which the
mechanism of maldigestion is complex. It seems that faecal fat
quantification and the 13C-mixed triglyceride breath test are the
most accurate and thus most important tests available in clinical
practice.3,4
The aim of therapy for EPI is to reverse all secondary clinical
events caused by enzyme deficiency. In order to achieve this goal,
a combination of general and dietary measures together with oral
PERT is mandatory. This requires the patient to maintain a
balanced diet that accounts for glucose tolerance and considers fat
consumption. Standard treatment should include oral pancreatic
enzymes, which have been proven in many studies to effectively
control patient nutritional status and prevent longterm malnutri-
tion, excessive weight loss and severe symptoms by improving the
absorption of dietary fat and protein. Independent of the avail-
ability of a test to detect EPI, almost all patients who undergo
upper gastrointestinal surgery should receive PERT immediately
after surgery and should be subject to regular assessment to ensure
good nutritional status is maintained and symptoms are
adequately controlled.5
Needless to say, a combination of different enzymes, as pro-
vided by available PERT products, should be included in the
treatment regimen. Impairment of absorption concerns all the
different nutrients, but the maldigestion of fat is among the most
prominent. Not many adequately powered studies have compared
different enzyme preparations for the treatment of maldigestion
after gastrointestinal surgery. However, enteric-coated enzyme
microspheres have been shown to be associated with a higher gain
in body weight. Another important issue is PERT dose, which
should be individualized depending on the degree of maldigestion
and dietary fat content; using a PERT dose selected to meet the
needs of the individual patient can make substantial differences
in terms of efficacy.
Gastrointestinal surgeons are ideally placed to ensure that
their patients’ EPI is appropriately managed both in preparation
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for surgery, if necessary, and immediately following surgery, in
collaboration with gastrointestinal specialists and other health
professionals.
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